Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a large drop in short interest in May. As of May 29th, there was short interest totaling 2,772 shares, a drop of 67.1% from the May 14th total of 8,438 shares. Based on an average daily trading volume, of 7,331 shares, the days-to-cover ratio is presently 0.4 days.
Carl Zeiss Meditec Stock Down 0.6%
Shares of CZMWY traded down $0.17 during mid-day trading on Friday, reaching $28.97. 857 shares of the stock traded hands, compared to its average volume of 5,085. The firm has a fifty day moving average price of $30.43 and a 200 day moving average price of $35.85. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $72.57.
Analyst Upgrades and Downgrades
Separately, Zacks Research lowered Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research note on Monday, May 25th. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Read More
- Five stocks we like better than Carl Zeiss Meditec
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
